Literature DB >> 19231529

Comparison between open and thoracoscopic resection of congenital lung lesions.

N Rahman1, Kokila Lakhoo.   

Abstract

PURPOSE: This study compares the outcome between thoracoscopic and thoracotomy resection of congenital lung lesions.
METHODS: From November 2005 to August 2007, 14 consecutive cases of video-assisted thoracoscopic (VATS) lung resections have been performed in our institution. A retrospective review comparing these cases to the previous open thoracotomies for lung resection was performed. Intraoperative and early postoperative results were compared.
RESULTS: The mean age for VATS resection was 10 months compared with 7 months for thoracotomy. There were no major intraoperative complications. One case was converted from thoracoscopy to thoracotomy, and there was one anesthetic failed attempt of VATS resection, which was then performed open. Seven VATS resections and 6 thoracotomies were for congenital cystic adenomatous malformations. Intraoperative chest drains were used for all VATS resections but only 10 of the 14 thoracotomies, one of which developed a tension pneumothorax within hours of discharge. Perioperative outcomes including time to removal of chest drain, length of postoperative intravenous opioid requirement, and hospital stay were similar for both groups. Three had postoperative complications. Operative time was significantly lower in the thoracotomy group (124 minutes compared with 170 minutes, P < .05). The subgroup of congenital lobar emphysema had a particularly prolonged VATS resection time of 220 vs 155 minutes (P < .05). The thoracotomy group was more likely to receive adjuvant regional anesthesia (12 of 14 compared with 5 of 14).
CONCLUSIONS: Thoracoscopic resection of lung lesions results in longer operative time but is a safe and feasible alternative to open thoracotomy. Congenital lobar emphysema is a subgroup more challenging thoracoscopically, and it is recommended that these should be preselected for open surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19231529     DOI: 10.1016/j.jpedsurg.2008.10.081

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

Review 1.  Thoracoscopic Lobectomy for Congenital Lung Lesions.

Authors:  Jarrett Moyer; Hanmin Lee; Lan Vu
Journal:  Clin Perinatol       Date:  2017-09-28       Impact factor: 3.430

2.  Thoracoscopic resection of congenital cystic lung lesions is associated with better post-operative outcomes.

Authors:  C T Lau; L Leung; I H Y Chan; P H Y Chung; L C L Lan; K L Chan; K K Y Wong; P K H Tam
Journal:  Pediatr Surg Int       Date:  2013-04       Impact factor: 1.827

3.  Serial improvement of quality metrics in pediatric thoracoscopic lobectomy for congenital lung malformation: an analysis of learning curve.

Authors:  Samina Park; Eung Re Kim; Yoohwa Hwang; Hyun Joo Lee; In Kyu Park; Young Tae Kim; Chang Hyun Kang
Journal:  Surg Endosc       Date:  2017-02-15       Impact factor: 4.584

4.  Thoracoscopic lobectomy for congenital cystic lung diseases in neonates and small infants.

Authors:  Kenitiro Kaneko; Yasuyuki Ono; Takahisa Tainaka; Wataru Sumida; Yusuke Kawai; Hisami Ando
Journal:  Pediatr Surg Int       Date:  2010-01-28       Impact factor: 1.827

5.  Clinical and surgical aspects of congenital lobar over-inflation: a single center retrospective study.

Authors:  Mohamed Abdel-Bary; Mohamed Abdel-Naser; Ahmed Okasha; Mohammed Zaki; Khaled Abdel-Baseer
Journal:  J Cardiothorac Surg       Date:  2020-05-19       Impact factor: 1.637

6.  Is thoracoscopy superior to thoracotomy in the treatment of congenital lung malformations? An updated meta-analysis.

Authors:  Junhua Xie; Yuhao Wu; Chun Wu
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

7.  Congenital lobar emphysema: 30-year case series in two university hospitals.

Authors:  Daniele Cristina Cataneo; Olavo Ribeiro Rodrigues; Erica Nishida Hasimoto; Aurelino Fernandes Schmidt; Antonio José Maria Cataneo
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.